U.S. Health Secretary Robert F. Kennedy Jr. announced plans to reform the National Vaccine Injury Compensation Program (VICP), pledging to address what he calls inefficiencies and corruption within the system. Kennedy, a long-time vaccine skeptic and former vaccine injury lawyer, criticized the program’s “Vaccine Court” for failing to quickly and fairly compensate individuals harmed by vaccines.
In a post on X, Kennedy said he is working with Attorney General Pam Bondi to restore the program to its “original congressional intent,” arguing that its current structure unfairly positions the Department of Health and Human Services (HHS), which he leads, as the defendant rather than vaccine manufacturers.
This move continues Kennedy’s sweeping efforts to reshape U.S. vaccine and health policy. In June, he dismissed all 17 members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, replacing them with seven appointees, including figures with histories of questioning vaccine safety. One of these members previously earned significant fees as an expert witness against Merck’s Gardasil vaccine, a case in which Kennedy played a key role.
Kennedy is also reportedly considering removing members of another influential health advisory panel, the U.S. Preventive Services Task Force. His tenure at HHS has intensified scrutiny due to his longstanding promotion of vaccine skepticism, including discredited claims linking vaccines to autism and false statements about fetal cells in the measles vaccine.
The announcement comes amid one of the worst U.S. measles outbreaks in decades, further fueling debate over vaccine safety, public health policy, and Kennedy’s leadership approach.


Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Colombia’s Clan del Golfo Peace Talks Signal Mandatory Prison Sentences for Top Leaders
Trump Criticizes EU’s €120 Million Fine on Elon Musk’s X Platform
CFPB to Review Anti-Discrimination Policies and Fair Lending Rules Amid Policy Shift
Thailand Vows Continued Military Action Amid Cambodia Border Clash Despite Trump Ceasefire Claim
Trump Criticizes Insurers as Debate Over Extending Obamacare Subsidies Intensifies
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee
International Outcry Grows Over Re-Arrest of Nobel Laureate Narges Mohammadi in Iran
Syria Arrests Five Suspects After Deadly Attack on U.S. and Syrian Troops in Palmyra
International Stabilization Force for Gaza Nears Deployment as U.S.-Led Planning Advances
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Belarus Pledges to Halt Smuggling Balloons Into Lithuania
Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions
U.S. Intelligence Briefly Curtailed Information Sharing With Israel Amid Gaza War Concerns 



